Detalhe da pesquisa
1.
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Blood
; 135(17): 1438-1446, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315382
2.
Investigating the response of paediatric leukaemia-propagating cells to BCL-2 inhibitors.
Br J Haematol
; 192(3): 577-588, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452017
3.
Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK.
Br J Haematol
; 182(6): 777-788, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30125955
4.
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Haematologica
; 103(1): 107-115, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079599
5.
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.
Blood
; 124(9): 1434-44, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957142
6.
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Lancet Oncol
; 15(8): 809-18, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24924991
7.
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Lancet Oncol
; 14(3): 199-209, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23395119
8.
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
Leukemia
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744919
9.
Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial.
Haematologica
; 103(7): e288-e292, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519867
10.
The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 41(19): 3545-3556, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098241
11.
Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial.
J Clin Oncol
; 40(36): 4228-4239, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714315
12.
Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
Br J Haematol
; 153(2): 179-90, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21382019
13.
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Lancet
; 376(9757): 2009-17, 2010 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21131038
14.
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.
Eur J Cancer
; 151: 175-189, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010787
15.
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial.
Nat Med
; 27(10): 1797-1805, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642489
16.
Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting.
Haematologica
; 94(6): 870-4, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19377076
17.
Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial.
Lancet Haematol
; 6(4): e204-e216, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826273
18.
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category.
Leukemia
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760480
19.
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS.
Leukemia
; 33(9): 2254-2265, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227779
20.
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study.
Leukemia
; 33(9): 2241-2253, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243313